These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33173433)

  • 1. Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.
    Wu CC; Ekanem TI; Phan NN; Loan DTT; Hou SY; Lee KH; Wang CY
    Int J Med Sci; 2020; 17(18):3112-3124. PubMed ID: 33173433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct expression pattern and prognostic values of pituitary tumor transforming gene family genes in non-small cell lung cancer.
    Yang S; Wang X; Liu J; Ding B; Shi K; Chen J; Lou W
    Oncol Lett; 2019 Nov; 18(5):4481-4494. PubMed ID: 31611957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer.
    Kao TJ; Wu CC; Phan NN; Liu YH; Ta HDK; Anuraga G; Wu YF; Lee KH; Chuang JY; Wang CY
    Aging (Albany NY); 2021 Jul; 13(14):17970. PubMed ID: 34329194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer.
    Song X; Zhang T; Wang X; Liao X; Han C; Yang C; Su K; Cao W; Gong Y; Chen Z; Han Q; Li J
    Med Sci Monit; 2018 Dec; 24():9442-9464. PubMed ID: 30593585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-regulated PTTG1 promotes breast cancer progression by regulating cyclin kinase expression.
    Meng C; Zou Y; Hong W; Bao C; Jia X
    Mol Med; 2020 Apr; 26(1):33. PubMed ID: 32272902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpressing PTTG family genes predict poor prognosis in kidney renal clear cell carcinoma.
    Gui Y; Liu X; Wang C; Yang P
    World J Surg Oncol; 2021 Apr; 19(1):111. PubMed ID: 33845847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck.
    Solbach C; Roller M; Eckerdt F; Peters S; Knecht R
    BMC Cancer; 2006 Oct; 6():242. PubMed ID: 17029632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of pituitary tumor transforming gene in tumorigenesis.
    Tfelt-Hansen J; Kanuparthi D; Chattopadhyay N
    Clin Med Res; 2006 Jun; 4(2):130-7. PubMed ID: 16809406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pituitary tumor transforming gene in thyroid cancer.
    Lewy GD; Sharma N; Seed RI; Smith VE; Boelaert K; McCabe CJ
    J Endocrinol Invest; 2012 Apr; 35(4):425-33. PubMed ID: 22522436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
    Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
    Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
    Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
    Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PTTG on endogenous gene expression in HEK 293 cells.
    Panguluri SK; Kakar SS
    BMC Genomics; 2009 Dec; 10():577. PubMed ID: 19958546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High FAS expression correlates with a better prognosis and efficacy of taxanes and target regents in breast cancer.
    Zhang Y; Shao X; Gao C; Xu D; Wu J; Zhu X; Chen Z
    Cancer Biomark; 2021; 32(2):207-219. PubMed ID: 34092611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of pituitary tumor-transforming gene in endometrial cancer as a prognostic marker.
    Kim JW; Song JY; Lee JM; Lee JK; Lee NW; Yeom BW; Lee KW
    Int J Gynecol Cancer; 2008; 18(6):1352-9. PubMed ID: 18217976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumor-transforming gene and its binding factor in endocrine cancer.
    Smith VE; Franklyn JA; McCabe CJ
    Expert Rev Mol Med; 2010 Dec; 12():e38. PubMed ID: 21129230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.
    McCabe CJ; Khaira JS; Boelaert K; Heaney AP; Tannahill LA; Hussain S; Mitchell R; Olliff J; Sheppard MC; Franklyn JA; Gittoes NJ
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):141-50. PubMed ID: 12580928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhang J; Yang Y; Chen L; Zheng D; Ma J
    Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer.
    Boelaert K; McCabe CJ; Tannahill LA; Gittoes NJ; Holder RL; Watkinson JC; Bradwell AR; Sheppard MC; Franklyn JA
    J Clin Endocrinol Metab; 2003 May; 88(5):2341-7. PubMed ID: 12727994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenic potential of pituitary tumor transforming gene (PTTG) in vivo investigated using a transgenic mouse model, and effects of cross breeding with p53 (+/-) transgenic mice.
    Fong MY; Farghaly H; Kakar SS
    BMC Cancer; 2012 Nov; 12():532. PubMed ID: 23164239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.